Document Classification

Section Type: RESULTS

Text: At 1, 2, 4, 6 h after therapy, FEV1 % [(43 + / - + / - 5) %, (50 + / - 5) %, (57 + / - 5) %, (67 + / - 6) %], PEF % [(47 + / - 5) %, (55 + / - 6) %, (62 + / - 7) %, (69 + / - 7) %], clinical index (5. 1 + / - 0. 8, 4. 3 + / - 0. 6, 3. 5 + / - 0. 6, 2. 5 + / - 0. 4) in budesonide group and FEV1 % [(42 + / - 5) %, (44 + / - 5) %, (45 + / - 5) %, (45 + / - 5) %], PFE % [(46 + / - 5) %, (47 + / - 5) %, (49 + / - 6) %, (49 + / - 6) %], clinical index (5. 3 + / - 0. 7, 5. 0 + / - 0. 5, 4. 9 + / - 0. 7, 4. 8 + / - 0. 7) in control group were difference markedly compared with before therapy [budesonide group was (35 + / - 5) %, (38 + / - 5) %, 8. 3 + / - 1. 0, and control group was (33 + / - 5) %, (38 + / - 5) %, 8. 3 + / - 1. 1, respectively], all (P < 0. 01).